| Patents for C07J 9 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane (4,897) |
|---|
| 06/01/2006 | US20060116418 Materials and methods for treating hypercholesterolemia |
| 05/31/2006 | EP1660516A1 Compound and method for enhancing the cholesterol lowering property of plant sterol and stanol esters |
| 05/31/2006 | CN1778810A Ginseng dialcohol hypometaalcohol derivative, itspreparation and use |
| 05/31/2006 | CN1257914C Process for extracting oleanolic acid-3-O-beta-D pyrane glucuronide from general aralia chinensis saponin and its usage |
| 05/30/2006 | US7053076 Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugs |
| 05/30/2006 | CA2085831C Polymers and oligomers of bile acid derivatives, process for their preparation and their use as pharmaceuticals |
| 05/25/2006 | US20060111333 Structural, behavioral characterization, and synthesis of attractants for migratory lamprey |
| 05/24/2006 | EP1658305A1 Novel fusidic acid derivatives |
| 05/24/2006 | CN1775798A Method for producing high-purity chenodeoxy cholic acid from poultry and livestock bile |
| 05/17/2006 | CN1774242A Methods for preparation and use of 1alpha,24(s)-dihydroxyvitamin d2 |
| 05/17/2006 | CN1772760A Synthesis process of chlesterol and its intermediate |
| 05/17/2006 | CN1256346C Crosslinking monomer containing bile acid and preparation process and use thereof |
| 05/11/2006 | WO2006018019A3 SELECTIVE INHIBITORS OF 11ß-HYDROXYSTEROID DEHYDROGENASE TYPE 1 |
| 05/10/2006 | EP0924199B1 Crystals of vitamin d derivatives and process for the preparation thereof |
| 05/10/2006 | CN1771256A Cholesterol-containing compounds and their use as immunogens against borrelia burgdorferi |
| 05/09/2006 | US7041839 Therapy for hormone sensitivity disease; side effect reduction; anticancer agents |
| 05/04/2006 | WO2006047022A1 Nuclear sulfated oxysterol, potent regulator of cholesterol homeostasis, for therapy of hypercholesterolemia, hyperlipidemia, and atherosclerosis |
| 05/04/2006 | WO2006045745A1 Process for the preparation of 21-hydroxy steroids with control of the epimeric distribution at the c-21 position |
| 05/03/2006 | EP1652526A2 Use of (11beta, 17beta)-11-(1,3-benzodioxol-5-yl)-17-hydroxy-17-(1-propynyl)-estra-4,9-dien-3-one in the treatment of major depressive disorder |
| 05/03/2006 | CN1765917A Gen-seng saponin Rb2 preparation process |
| 05/03/2006 | CN1765916A Ergosterol preparation method |
| 05/03/2006 | CN1254480C Method for preparing high-content beta-sitosterin products by catalytic hydrogenation |
| 05/03/2006 | CN1254479C 3-methylene steroid derivative |
| 04/26/2006 | EP1648232A2 Method of treating hit patients with argatroban |
| 04/26/2006 | CN1763068A Method for extracting phytosterol acetate from plant oil asphalt |
| 04/25/2006 | US7034043 Cell adhesion inhibitors |
| 04/25/2006 | US7034006 Use of lipid conjugates in the treatment of disease |
| 04/19/2006 | EP1250350B1 Novel crystalline composites comprising phytosterols and phytostanols or derivatives thereof |
| 04/19/2006 | CN1252083C Process for synthesizing 20(S)-ginsenoside Rh2 |
| 04/19/2006 | CN1252082C Process for preparing protopanoxadiol and protopanaxatriol |
| 04/19/2006 | CN1251678C Medicinal composition and tuchahoe extract for raising immunity |
| 04/12/2006 | EP1644400A2 Sterol recovering method |
| 04/12/2006 | EP1644399A2 Novel compounds and compositions comprising sterols and/or stanols and cholesterol biosynthesis inhibitors and use thereof in treating or preventing a variety of diseases and conditions. |
| 04/12/2006 | EP0912179B1 Deoxynojirimycin derivatives and their uses as glucosylceramidase inhibitors |
| 04/05/2006 | CN1249077C Method for preparing anti-tumour ginseng saponin aglycone derivatives |
| 04/05/2006 | CN1249076C Anti-tumour ginseng saponin aglycone derivatives |
| 04/05/2006 | CN1249075C Method for preparing true aglycone of ginseng saponin |
| 03/29/2006 | EP1640009A1 Estrogenic compounds as antimitotic agents |
| 03/29/2006 | CN1752095A C27-steroid antitumour medicine |
| 03/22/2006 | EP1226157B1 Process for the purification of phytosterol from fatty acids and their esters |
| 03/16/2006 | WO2004085458A3 Steroid spirolactonization |
| 03/15/2006 | CN1245415C Extraction of panax notoginseng leaf saponine |
| 03/14/2006 | US7012070 Estrogenic compounds as anti-mitotic agents |
| 03/14/2006 | US7012069 For therapy of heart disease and stroke, Alzheimer's disease, and an inflammatory disorder |
| 03/09/2006 | WO2006024296A1 Epimerisation of allylic alcohols |
| 03/08/2006 | EP1631580A2 Methods for the preparation of dhea derivatives |
| 03/08/2006 | EP1240179B1 3-methylene steroid derivatives for the treatment of autoimmune diseases |
| 03/08/2006 | CN1745090A Steroid compounds with anti-tumor activity |
| 03/08/2006 | CN1743337A Taxol derivative and its pharmaceutical composition |
| 03/07/2006 | US7008900 Double metal cyanide catalysts for producing polyether polyols |
| 03/01/2006 | EP1494691A4 Treatment of diseases involving defective gap junctional communication |
| 03/01/2006 | CN1243767C Immunomodulatory steroids, in particular hemihydrate of 16 alpha-bromoepiandrosterone |
| 02/23/2006 | CA2573699A1 Compounds and their preparation for the treatment of alzheimer's disease by inhibiting beta-amyloid peptide production |
| 02/22/2006 | CN1243011C Cholesterin derivative containing azobenzol group and its synthesis and use |
| 02/21/2006 | US7002030 Substance for lowering high cholesterol level in serum and methods for preparing and using the same |
| 02/21/2006 | US7002027 Drug delivery enhancing agents with cholic acid and monosaccharide groups for treating cancer by gene therapy; tissue or organs having an epithelial membrane |
| 02/15/2006 | EP1441739B1 Use of (11beta, 17beta)-11-(1,3-benzodioxol-5-yl)-17-hydroxy-17-(1-propynyl)-estra-4,9-dien-3-one in the treatment of major depressive disorder |
| 02/15/2006 | CN1733662A Antineoplastic extract of Chinese fan palm and its preparation method and uses |
| 02/09/2006 | US20060030551 Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugs |
| 02/08/2006 | EP1451132A4 Chemical synthesis |
| 02/02/2006 | WO2006010307A1 A synthetic method of 20 (s)-ginsenoside rh2 |
| 01/31/2006 | US6992076 Providing sustained systemic concentrations of therapeutic or prophylactic agents such as gamma-aminobutyric acid derivatives following oral adiminstration to animals |
| 01/25/2006 | EP1618121A1 Process for preparing ursodeoxycholic acid di-sodium 3,7-disulfate |
| 01/25/2006 | EP1617810A2 Methods for preparation and use of 1alpha,24(s)-dihydroxyvitamin d2 |
| 01/25/2006 | CN1724555A Method for extracting and purifying beta-sitosterin from remnant of rapeseed oil |
| 01/25/2006 | CN1724554A 1,4-pregnandiene 17 alpha, 21'-dihydroxy-3,20-diketone-17 alpha, 21-diacetate |
| 01/24/2006 | US6989456 Process for producing edible sterol fatty acid esters |
| 01/19/2006 | WO2006006718A1 Process for production of steroids |
| 01/19/2006 | US20060014729 Compounds and their preparation for the treatment of Alzheimer's disease by inhibiting beta-amyloid peptide production |
| 01/19/2006 | US20060014289 Methods and compositions for enhancing delivery of double-stranded RNA or a double-stranded hybrid nucleic acid to regulate gene expression in mammalian cells |
| 01/19/2006 | CA2573613A1 A method for producing a steroid compound |
| 01/18/2006 | CN1237071C Conjugates of phytosterol or phytostanol with ascorbic acid and use thereof in treating or preventing cardiovascular disease |
| 01/18/2006 | CN1236763C Use of an epoxy-sterodal aldosterone antagonist for the treatment or prophylaxis of aldosterone-mediated pathogenic effects |
| 01/12/2006 | CA2572872A1 Tissue factor production inhibitor |
| 01/11/2006 | EP1613641A2 Cholesterol-containing compounds and their use as immunogens against borrelia burgdorferi |
| 01/11/2006 | CN1235907C Synthesis method of plant sterol-beta-D-glucoside or/and plant steroid alkanol-beta-D-glucoside compound |
| 01/10/2006 | US6984634 For prophylaxis and therapy |
| 01/10/2006 | CA2425841C Angiostatic steroids |
| 01/04/2006 | CN1715290A Dengxin subergorgia saponin |
| 01/04/2006 | CN1234723C Method for extracting fucosterol from alga |
| 01/04/2006 | CN1234722C Preparation process for ginsenoside Rb1 |
| 01/03/2006 | US6982092 Method of complexing a nucleic acid with a lipid-conjugated polyamide |
| 12/29/2005 | WO2004082631A3 METHODS FOR PREPARATION AND USE OF 1α,24(S)-DIHYDROXYVITAMIN D2 |
| 12/28/2005 | EP1177159B1 Fluorination in liquid carbon dioxide |
| 12/27/2005 | US6979743 Cooling, crystallizing in a hydrocarbon solvent mixture containing methanol, producing high yield and pure sterols, a transesterification products from rapeseed oil or sunflower oil distillation residue; food additives, anticholesterol agents |
| 12/21/2005 | EP1606306A2 Steroid spirolactonization |
| 12/21/2005 | EP0713393B1 Estrogenic compounds as anti-angiogenesis agents |
| 12/14/2005 | EP1603934A1 Ethercarboxylic acid ester of sterol or stanol |
| 12/14/2005 | EP1465968A4 Methods for treating deodorizer distillate |
| 12/14/2005 | CN1708508A Method of separating ergosterol |
| 12/14/2005 | CN1706861A Prepn and use of high-purity momordica glycoside V |
| 12/08/2005 | WO2005116048A1 Process for the recovery of sterols from organic material |
| 12/08/2005 | US20050272711 Substance for lowering high cholesterol level in serum and methods for preparing and using the same |
| 12/08/2005 | US20050271791 Methods for producing sterol esters of omega-3 fatty acids |
| 12/07/2005 | EP1601363A2 Use of derivatives of cholest-4-en-3-one as medicaments, pharmaceutical compositions containing same, novel derivatives and preparation method thereof |
| 12/07/2005 | CN1704428A An polyspike acid ester as antitumor active component and its preparation process and use |
| 12/07/2005 | CN1704427A Protopanoxadiol lower alcohol derivatives and process for preparing same |
| 11/29/2005 | CA2123048C Tetrazole derivatives of bile acids, processes for their preparation and the use of these compounds as medicaments |
| 11/24/2005 | WO2005082925A3 Novel steroid agonist for fxr |
| 11/24/2005 | US20050261508 Aminosterol compounds useful as inhibitors of the sodium/proton exchanger (NHE), pharmaceutical methods and compositions employing such inhibitors, and processes for evaluating the NHE-inhibitory efficacy of compounds |